NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:51 PM
NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 03:51 PM
Recent news on Agomab Therapeutics NV
See all newsBrief: Agomab Announces First Patient Dosed In Global Nov-Era Phase 2B Study Of Ontunisertib In Fibrostenosing Crohn's Disease
Brief: Agomab Reports Positive Topline Data From Stenova Open-Label Extension Study Of Ontunisertib In Fibrostenosing Crohn's Disease
Brief: Agomab Announces Appointments Of Marino Garcia And Dr Naimish Patel To Board Of Directors
Brief: Agomab Announces Proposed Appointments Of Marino Garcia And Dr. Naimish Patel To Board Of Directors
NASDAQ RESUMED AT 04:00 PM